Education Background
- B,Sc, in Pharm.
- M.S. (Pharm)
- Ph.D.
Work Experience
Expertise
- Pharmacovigilance, Medication Safety
Award & Honor
- Figure 1: Discuss on Pharmacovigilance in Thailand at the New Western Pacific Chapter of ISoP at the 7th ISoP annual meeint in 2007.
- Figure 2: Won the first place at the Pharmacovigilance Quiz Bowl in the 5th International Society of Pharmacovigilance (ISoP) Annual Meeting in 2005.
Current Research
Publication
Year 2026
Ho HTT, Vo HT, Tragulpiankit P, Nathisuwan S.
Clin Transl Sci 2025 Mar 4 , 2026.
Year 2025
da Costa J; Nosoongnoen W; Rungapiromnan W; Tragulpiankit P.
Clinical and Translational Science 2025 Jan;9(1):69-81 , 2025.
Year 2024
Huynh BH; Vo HT; Pham ATK; Tragulpiankit P; Huynh NH; Nguyen NL; Nguyen LT; Hong Pham T; Nathisuwan S.
JACCP Journal of the American College of Clinical Pharmacy 2024; 7():544-553 , 2024.
Surarak T; Chumnumwat S; Nosoongnoen W; Tragulpiankit P.
Clinical and Translational Science 2024; (e13795):- , 2024.
Year 2023
Huynh BH; Nathisuwan S; Tragulpiankit P; Nguyen VD; Huynh NH; Vu TLA; Huynh LTH; Vo HT.
Journal of Pharmacy Technology 2023 Dec;39(6):259-268 , 2023.
Year 2022
Costs Associated with Adverse Drug Reactions Among HIV/TB Patients in Thailand
Rochanathimoke O, Tragulpiankit P, Turongkaravee S, Jittikoon J, Udomsinprasert W, Chaikledkeaw U.
Clinicoecon Outcomes Res 2022 Sep 7;14:587-599 , 2022.
Win EE, Htun KW, Tragulpiankit P, Tangtrakultham S, Montakantikul P.
Infection and Drug Resistance 2022 Feb 11;15:439-453 , 2022.
Benjawan S, Nimitphong H, Tragulpiankit P, Musigavong O, Prathanturarug S, Pathomwichaiwat T.
Phytomedicine 2022 Sep 23;86(10):1368-1377 , 2022.
Year 2021
Colistin dosing regimens against pseudomonas aeruginosa in critically ill patients: An application of monte carlo simulation
Nguyen VTK, Montakantikul P, Tragulpiankit P, Houngsaitong J, Shuib MF..
Antibiotics 2021; 10(5): 595., 2021.
HLA-A*24:07 as a potential biomarker for carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in Filipino patients
Capule F, Tragulpiankit P, Mahasirimongkol S, Jittikoon J, Wichukchinda N, Alentajan-Aleta LT, Barit J-VJ, Casanova-Gutierrez J, Cabral-Lim L, Baltazar Reyes JP, Roa F, Salonga R, San Gabriel KF, Silao CL..
Pharmacogenomics 2021; 22(8): 465-472., 2021.
Year 2020
Association of carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis with the HLA-B75 serotype or HLA-B*15:21 allele in Filipino patients.
Capule F*, Tragulpiankit P, Mahasirimongkol S, Jittikoon J, Wichukchinda N, Theresa Alentajan-Aleta L, James Barit JV, Casanova-Gutierrez J, Cabral-Lim L, Baltazar Reyes JP, Roa F, Salonga R, San Gabriel KF, Lynn Silao C..
Pharmacogenomics journal 2020; 20(3): 533-541., 2020.
Knowledge, attitude, and practice towards pharmacogenomics among hospital pharmacists in Thailand
Karuna N, Tragulpiankit P, Mahasirimongkol S, Chumnumwat S*..
Pharmacogenet genomics 2020; 30(4): 73-80., 2020.
The efficacy of honey and a Thai Herbal Oil preparation in the treatment of pressure ulcers based on Thai traditional medicine wound diagnosis versus standard practice: An open-label randomized controlled trial
Chotchoungchatchai S, Krairit O, Tragulpiankit P, Prathanturarug S*..
Contemporary clinical trials communications 2020; 17: 100538., 2020.
Year 2019
Pharmacokinetics and penetration of sitafloxacin into alveolar epithelial lining fluid in critically ill Thai patients with pneumonia
Paiboonvong T, Nosoongnoen W*, Sathirakul K*, Tangsujaritvijit V, Kaemapairoj J, Tragulpiankit P*, Montakantikul P*..
Antimicrob Agents Chemother 2019; 63(10)., 2019.
Year 2018
Carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis overlap in a Filipino with positive HLA-B75 serotype
Capule F, Tragulpiankit P, Mahasirimongkol S, Wichukchinda N, Jittikoon J, Alentajan-Aleta LT, Jay-V James Barit, Casanova-Gutierrez J, Cabral-Lim L, Baltazar Reyes JP, Roa F, Katrina Faith San Gabriel, Catherine Lynn Silao..
BMJ Case Reports 2018 (Article in Press), 2018.
Paiboonvong T, Pummangura C, Tedtaisong P, Thamlikitkul V, Tragulpiankit P, Suansanae T, Sukkha S, Montakantikul P.*.
Pharmaceutical Sciences Asia 2018; 45(2): 105-113, 2018.
Year 2016
Jittikoon J, Mahasirimongkol S, Charoenyingwattana A, Chaikledkaew U, Tragulpiankit P, Mangmool S, Inunchot W, Somboonyosdes C, Wichukchinda N, Sawanpanyalert P, He Y.f, Mcleod H.L.f, Chantratita W*..
Journal of Human Genetics. 2016; 61(2): 119-127., 2016.
Dorji C, Tragulpiankit P*, Riewpaiboon A, Tobgay T..
Drug Safety 2016; 39(12): 1239-1250., 2016.
Year 2015
Comparison of genetic variation in drug ADME-related genes in Thais with Caucasian, African and Asian HapMap populations.
Jittikoon J, Mahasirimongkol S, Charoenyingwattana A, Chaikledkaew U, Tragulpiankit P, Mangmool S, Inunchot W, Somboonyosdes C, Wichukchinda N, Sawanpanyalert P, He Y, McLeod HL, Chantratita W*..
Journal of Human Genetics 2015; 1-9, 2015.
Evaluation of Thai and Narnajo’s Algorithm for Assessing Routine Pharmacovigilance Case Reports Using WHO-UMC Causality Assessment Criteria as Reference
Suwankesawong W, Sriphiromya P, Tragulpiankit P, Phetcharat C, Sornsrivichai V, Pokhagul P..
Drug Safety 2015; 38(10): 1019-1020, 2015.
Knowledge About Adverse Drug Reaction and Reporting Among the Healthcare Professionals in Bhutan
Dorji C, Tragulpiankit P, Riewpaiboon A, Tobgay T..
Drug Safety 2015; 38(10): 946-946, 2015.
Patterns of Spontaneously Reported Adverse Drug Reaction in Bhutan
Dorji C, Tragulpiankit P, Dema N..
Drug Safety 2015; 38(10): 981-981, 2015.
Year 2014
Adverse Drug Event of Hospitalized Patients from Multi-Hospitals in Thailand
Tragulpiankit P, Yeesoonpan N, Ninsananda T, Chindavijak B, Chulavatnatol S, Chaikledkaew U, Uaviseswong T..
Pharmacoepidemiology and drug safety 2014; 23: 289-289, 2014.
Drug Discrepancy and Medication Error of Admitted Patients by Medication Reconciliation Process
Unin J, Tragulpiankit P, Ningsananda T, Nilpetchploy R..
Pharmacoepidemiology and drug safety 2014; 23: 122-123, 2014.
Drug-Related Hospital Readmission in Community Hospital, Thailand
Unin J, Tragulpiankit P, Moungnoi C, Channalao P..
Pharmacoepidemiology and drug safety 2014; 23: 123-123, 2014.
Year 2013
Attitudes among healthcare professionals to the reporting of adverse drug reactions in Nepal.
KC S, Tragulpiankit P*, Gorsanan S, Edwards R..
BMC Pharmacology and Toxicology 2013; 14-16., 2013.
Knowledge about adverse drug reactions reporting among healthcare professionals in Nepal
Kc S, Tragulpiankit P*, Edwards IR, Gorsanan S..
International Journal of Risk and Safety in Medicine 2013; 25(1): 1-16, 2013.
Strengthening the Pharmacovigilance Programme in Nepal
Santosh KC, Tragulpiankit P*, Gorsanam P, Edwards IR, Alam K..
Nepal Journal of Epidemiology 2013; 3(1): 230-235, 2013.
Year 2012
Monmaturapoj T, Montakantikul P, Mootsikapun P*, Tragulpiankit P..
International Journal of Infectious Diseases 2012; 16(12): 843-849, 2012.
Adverse drug events in rheumatoid arthritis and osteoarthritis ambulatory patients
Tragulpiankit P*, Chulavatnatol S, Rerkpattanapipat T, Janwityanujit S, Somjarit S, Sirikhedgon U..
International Journal of Rheumatic Diseases 2012; 15(3): 315-321, 2012.
Systematic Review of Economic Evaluation of Pharmacist Intervention Related to Adverse Drug Event Prevention among Patients with Hospitalization.
Uaviseswong T, Chaikledkaew U*, Tragulpiankit P..
Mahidol University Journal of Pharmaceutical Sciences 2012; 39(1): 38-43., 2012.
Year 2011
Measured versus estimated creatinine clearance in elderly patients
Tragulpiankit P, Montakantikul P, Chulavatnatol S, Chansirikarnjana S, Thawinwang A..
Journal of Applied Therapeutic Research 2011; 8(2): 43-51, 2011.
Year 2009
Incidence of Medication Errors in Medication Reconciliation at General Medical Wards, Ramathibodi Hospital
Paiboonvong T, Montakantikul P*, Chansirikarnjana S, Tragulpiankit P..
Mahidol J Pharm. Sci 2009; 36(1-4): 44-49., 2009.
Pharmacist Participation in the Reduction of Preventable Adverse Drug Reactions in Thai Hospitalised Patients
Tragulpiankit P, Kaojarern S, Pummangura C, Wananukul W, Luscombe DK..
Journal of Applied Therapeutic Research 2009;7(1), 2009.
Year 2008
Prevalence and characteristics of adverse drug events in rheumatoid arthritis and osteoarthritis ambulatory patients at a large teaching hospital, Thailand.
Limsuwan T, Tragulpiankit P, Chulavatnatol S, Janwityanujit S, Sirikhedgon U, Somjarit S..
European Journal of Dermatology 2008;18:262-3., 2008.
Year 2007
Adverse Drug Event of Rheumatoid Arthritis and Osteoarthritis Ambulatory Patients in a Large
Tragulpiankit P, Chulavatnatol S, Limsuwan,T , Sirikhedgon U, Somjarit S.
Drug Safety 2007; 30(10): 950., 2007.
Development of a New Causality Assessment Method for Thai Adverse Drug Reaction Monitoring and Reporting
Suwankesawong W, Tragulpiankit P, Yothapitak J, Songsiriphun R..
Drug Safety 2007; 30(10): 948.., 2007.
Drug Therapy Problem Management by Pharmacist in Paediatric Intensive Care Unit at a Large Teaching Hospital, Thailand
Piebpien P, Tragulpiankit P, Preutthipan A, Montakantikul P..
Drug Safety 2007; 30(10): 949, 2007.
Year 2006
Preliminary review of Thai pharmacists
Tragulpiankit P, Chulavatnatol S..
Drug Saf 2006;29:976., 2006.
Year 2005
Prevention of adverse drug reactions in hospitalised patients by pharmacist participation at a large teaching hospital in Thailand.
Tragulpiankit P, Pummangura C, Luscombe DK, Kaojarern S, Wananukul W, Montakantikul P, Nathisuwan S..
Drug Safety 2005;28(10):931., 2005.
Year 2004
Characteristics of adverse drug reactions and patient at risk in medical wards.
Pummangura C, Tragulpiankit P, Kaojarern S, Wananukul W, Montakantikul P, Luscombe DK, Pomyen N. .
Pharmacy World & Science 2004;26:A100., 2004.
Reducing the risk of drug-induced adverse events in hospitalized patients.
Tragulpiankit P, Kaojarern S, Wananukul W, Luscombe DK. .
Pharmacy World & Science 2004;26:A100., 2004.
Year 2003
Characteristics of adverse drug reactions and patients at risk in medical wards, Ramathibodi Hospital.
Pummangura C, Tragulpiankit P, Kaojaroen S, Wananukul W, Montakantikul P,Luscombe DK, Pomyen N. .
Mahidol University Journal of Pharmaceutical Sciences 2003;30(3):25-31., 2003.
Year 2002
Potential adverse drug interaction in prescriptions of patients with cardiovascular diseases.
Chulavatnatol S, Tragulpiankit P, Ruengcharoenrung K, Janpraparn J, Aumklad P. .
Thai Journal of Hospital Pharmacy 2002;12(1):18-30., 2002.
Year 2001
Drug allergy history study of ambulatory patients.
Tragulpiankit P, Ruengcharoenrung K, Avihingsanon S, Cheadchaykeat M, Maneepan Y. .
Thai Journal of Hospital Pharmacy 2001;11(3):19-28., 2001.
Year 1999
An inpatient surveillance of adverse drug reactions in medical wards, in a teaching hospital, Thailand.
Tragulpiankit P, Wananukul W.
European Journal of Clinical Pharmacology 1999;55A47., 1999.
Year 1996
In-patient adverse drug reaction monitoring at the Department of Medicine, Ramathibodi Hospital.
Chindavijak B, Tragulpiankit P, Kaojarern S, Pummangura C..
Ramathibodi Med J 1996, 19: 17-25., 1996.
Presentation
Year 2018
Pharmacist’s Role in Risk Reduction of Carbamazepine-induced Stevens-Johnson Syndrome/ Toxic Epidermal Necrolysis through Biomarker Testing
Capule F, Tragulpiankit P..
18th Asian Conference on Clinical Pharmacy (ACCP) 2018 , 2018.
Year 2015
Adverse Drug Events Identified by Thai ADEs Trigger Tool in Hospitalized Patients in Thailand
Paiboonvon T, Tragulpiankit P, Viriyakul N, Iamchoo W, Promtasarn K, Sangviroon A.
Drug Safety 2015; 38(10): 1018-1018, 2015.
Evaluation of Thai and Narnajo’s Algorithm for Assessing Routine Pharmacovigilance Case Reports Using WHO-UMC Causality Assessment Criteria as Reference
Suwankesawong W, Sriphiromya P, Tragulpiankit P, Phetcharat C, Sornsrivichai V, Pokhagul P..
Drug Safety 2015; 38(10): 1019-1020, 2015.
Knowledge About Adverse Drug Reaction and Reporting Among the Healthcare Professionals in Bhutan
Dorji C, Tragulpiankit P, Riewpaiboon A, Tobgay T..
Drug Safety 2015; 38(10): 946-946, 2015.
Patterns of Spontaneously Reported Adverse Drug Reaction in Bhutan
Dorji C, Tragulpiankit P, Dema N..
Drug Safety 2015; 38(10): 981-981, 2015.
Year 2013
A meta-anlysis of genetic variation in CYP2C19 gene on drug interaction between clopidogrel and proton pump inhibitors in patients with cardiovascular diseases
Kritsanapipat D*, Jaroenporn P, Jittikoon J, Chaikedkaew U, Tragulpiankit P, Mahasirimongkol S, Charoenyingwattana A, Suvichapanich S, Sanrattana W, Chantratita W..
Pharma Indochina VIII ASEAN Pharmacy - Integration for Development, Vietnam. on 4 - 5 December 2013 , 2013.
Year 2008
Prevalence and characteristics of adverse drug events in rheumatoid arthritis and osteoarthritis ambulatory patients at a large teaching hospital, Thailand.
Limsuwan T, Tragulpiankit P, Chulavatnatol S, Janwityanujit S, Sirikhedgon U, Somjarit S..
3rd Drug Hypersensitivity Meeting , 11-13 April, 2008, Paris , 2008.
Training Course For Improvement Of Thai Adr Monitoring And Reporting.
Tragulpiankit P..
22nd Federation of Asian Pharmaceutical Associations Congress (FAPA 2008), 7 – 10 November 2008, Grand Copthorne Waterfront Hotel, Singapore. , 2008.
Year 2006
Measured versus estimated creatinine clearance in Thai elderly patients.
Thawinwang A, Montakantikul P, Chansirikarnjana S, Chulavatnatol S, Tragulpiankit P..
งานประชุมวิชาการประจำปี สมาคมเภสัชกรรมโรงพยาบาล (ประเทศไทย) เรื่อง ”The Next Step of Hospital Pharmacist to Quality Pharmacy Service” ณ อาคารเฉลิมพระบารมี ๕๐ ปี แพทยสมาคมฯ กรุงเทพฯ วันที่ 17 - 19 พฤษภาคม พ.ศ. 2549. 2006, 2006.
Year 2002
Pharmacist participation in therapeutic phenytoin monitoring. (oral presentation)
Chulavatnatol S, Tragulpiankit P, Chanawong A, Viranuvatti K, Wananukul W..
งานประชุมวิชาการประจำปี สมาคมเภสัชกรรมโรงพยาบาล (ประเทศไทย) เรื่อง ”Facing Changes in Pharmacotherapy and Pharmacy Profession” กรุงเทพฯ วันที่ 22 - 24 พฤษภาคม พ.ศ. 2545. 2002, 2002.
Year 2001
ปฏิกิริยาระหว่างยาที่พบในใบสั่งยาของผู้ป่วยโรคหัวใจ
สุวัฒนา จุฬาวัฒนทล ปราโมทย์ ตระกูลเพียรกิจ กมลศักดิ์ เรืองเจริญรุ่ง จารุณี จันทร์ประพาฬ ปอรวัลย์ อ่ำกลัด..
งานประชุมวิชาการประจำปี สมาคมเภสัชกรรมโรงพยาบาล (ประเทศไทย) เรื่อง “DUE: A Stepwise Approach for Rational Drug Use” กรุงเทพฯ วันที่ 23 - 25 พฤษภาคม พ.ศ. 2544. 2001, 2001.